SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk
FAS 135.22+4.0%Oct 15 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GROUND ZERO™ who wrote (160178)9/3/2021 4:53:23 PM
From: Winfastorlose8 Recommendations

Recommended By
GROUND ZERO™
isopatch
JMTrader
Mick Mørmøny
roguedolphin

and 3 more members

   of 162227
 
CDC Endorsed Use of Ivermectin . . . For Afghan Refugees!

(courtesy of Fubho)

.
"I have long been convinced that Nature has all the solutions we need to solve our past ... that will be the primary source of the treasures and solutions that we seek." ~Professor Satashi Omura, Nobel co-laureate for the discovery of ivermectin

Looking at 2019 CDC guidance, one has to wonder if one of the reasons why there is such a run on ivermectin is because our own government is using it. And no, not for horses, but for refugees. Yet these same government agencies are running a blood libel-style smear campaign against the drug and its users by misleading people into conflating it with a veterinarian version of the drug, leading many people to think it's some sort of poison for humans. In the process, they are leaving thousands of COVID patients without any other options for treatment.

It's not clear whether the hundreds of thousands of Afghan refugees will be forced to get vaccinated like American international travelers, but one thing is clear: They will likely get the ivermectin that most Americans can no longer access. It turns out that in 2019, the CDC issued guidance for refugees from Africa, Latin America, and the Middle East to be given ivermectin pre-emptively for potential infections. ...

As for the drug's exact mechanism of action against COVID, Dr. Ryan Cole, a brilliant Mayo Clinic-trained pathologist, listed eight different mechanisms in an exclusive interview with TheBlaze:

1. Inhibits binding at ACE2 and TMPRSS2, keeping the virus from entering our cells.

2. Blocks alpha/beta importin (the virus cell taxi), keeping it from getting to the nucleus.

3. Blocks the viral replicase zipper (RdRp).

4. 3-Chimotrypsin protease inhibition (keeps the virus from assembling).

5. Ivermectin strengthens our natural antiviral cell activity by increasing our natural interferon production (this counters SARSCOV2 activity, which inhibits cellular interferon).

6. Decreases IL-6 and other inflammatory cytokines through NF Kappa Beta downregulation, taking the patient from a cytokine storm to calm.

7. Binds NSP14, necessary for viral replication, and blocks it (equals less virus).

8. Most important mechanism is inhibiting binding to CD147 receptor on red cells, platelets, lung, and blood cell lining. Ivermectin keeps the virus from binding here and decreases deadly clotting.

For those who want a more detailed explanation of each of these mechanisms, Dr. Cole has provided me with important links and videos, which I posted together in this twitter thread:

BIDEN'S NEW 150,000 REFUGEES ARE BEING GIVEN IVERMECTIN

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext